Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
IL-4 (human) (monomeric):Fc (LALA-PG)-KIH (human) (rec.)
Product Details | |
---|---|
Synonyms | InVivoKine™; IL-4 (human) (monomeric):Fc (LALA-PG) Knobs-into-Holes (human) (rec.); Interleukin-4; B Cell Stimulatory Factor 1; BSF-1 |
Product Type | Protein |
Properties | |
Source/Host | HEK 293 cells. Produced using animal component-free medium. |
Sequence |
Human IL-4 (aa 25-153) is fused at the C-terminus to the Fc portion of human IgG1 (LALA-PG) (Knobs-into-Holes technology) (see reference: J.B. Ridgway, et al.; Protein Eng. 9, 617 (1996)). |
Crossreactivity | Human |
MW | ~50kDa and 28kDa (SDS-PAGE) |
Purity | ≥95% (SDS-PAGE) |
Endotoxin Content | <0.002 EU/μg protein (LAL test). |
Concentration | After reconstitution: 1mg/ml |
Reconstitution | Reconstitute with 50μl endotoxin-free water. |
Accession Number | P05112 |
Formulation | Lyophilized. Contains PBS. |
Protein Negative Control |
Fc (LALA-PG)-KIH (human) IgG1 Control (rec.) (Prod. No. AG-35B-0018) |
Other Product Data |
Uniprot link P05112: IL-4 (human) |
Shipping and Handling | |
Shipping | BLUE ICE |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice |
After reconstitution, prepare aliquots and store at -20°C. Avoid freeze/thaw cycles. Centrifuge lyophilized vial before opening and reconstitution. PBS containing at least 0.1% BSA should be used for further dilutions. |
Use/Stability |
Stable for at least 6 months after receipt when stored at -20°C. Working aliquots are stable for up to 3 months when stored at -20°C. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Interleukin-4 (IL-4) is a monomeric TH2 cytokine of approximately 17 kDa that shows pleiotropic effects during immune responses. It functions as a potent regulator of immunity. IL-4 was first identified as a T cell-derived growth factor for B cells. IL-4 and IL-13 activate many common signaling pathways. IL-4 is mainly produced by Th2 cells, but can also be secreted by natural killer T (NKT) cells, mast cells, eosinophils, basophils, and innate-type lymphoid cells. IL-4 can signal through the type II IL-4 receptor, which is a heterodimer of IL-4Rα and IL-13Rα1 chains, and also through the type I IL-4 receptor, which is a heterodimer of IL-4 receptor alpha (IL-4Rα) and common γ(γc) chains. IL-4 binding results in tyrosine kinase Janus kinase 1 (JAK1) and JAK3 activation.
IL-4 and IL-13 may be involved at several levels of the fibrotic process since they activate the fibroblasts that differentiate into myofibroblasts, and they stimulate extracellular matrix (ECM) production and deposition. IL-4 functions as a co-mitogen of B-cells. It is important in leukocyte survival, Th2 cell-mediated immunity, IgE class switching in B cells, and tissue repair and homeostasis through “alternative” macrophage activation.
The protein IL-4 (human) (monomeric):Fc (LALA-PG)-KIH (human) (rec.) is produced by using two different vectors, one encoding for the IL-4 (human):Fc (LALA-PG) Knobs sequence (synthesizing a protein of 50kDa) and one encoding for the Fc (LALA-PG) Holes sequence (synthesizing a protein of 28kDa). Both vectors transfected into HEK293 cells produce both Fc molecules (Knobs-into-Holes technology; J.B. Ridgway, et al.; Protein Eng. 9, 617 (1996)) required for dimerization of the Fc moieties and for secretion of the final protein IL-4 (human) (monomeric):Fc-KIH (human) (rec.). The LALA-PG mutations inhibit binding to FcγRs and C1q while FcRn binding and Fc stability remain unaffected.
InVivoKines™ are a new generation of recombinant fusion proteins for immunotherapeutic, preclinical and translational in vivo research, developed and manufactured by AdipoGen Life Sciences.